Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Downgrades NeoGenomics to Hold

Needham Downgrades NeoGenomics to Hold

Needham analyst Mike Matson downgrades NeoGenomics (NASDAQ:NEO) from Buy to Hold.

byBenzinga Newsdesk

August 22, 2022

1 minute read

Needham analyst Mike Matson downgrades NeoGenomics (NASDAQ:NEO) from Buy to Hold.

Analyst Ratings

The Latest Analyst Ratings for American Tower

By Benzinga Insights

December 14, 8:00 AM

Analysts have provided the following ratings for American Tower (NYSE:AMT) within the last quarter: Bullish Somewhat Bullish Indifferent…

AMT

B of A Securities Maintains Buy on Amazon.com, Lowers Price Target to $137

By Benzinga Newsdesk

October 28, 7:01 AM

B of A Securities analyst Justin Post maintains Amazon.com (NASDAQ:AMZN) with a Buy and lowers the price target from $157 to $137.

AMZN

Processa Pharmaceuticals Provides Interim Analysis From Ongoing Phase 1b Trial Of Next Generation Capecitabine Showing Improved Safety Over Capecitabine

By Benzinga Newsdesk

December 19, 10:05 AM

FDA acknowledges that NGC-Cap is a New Chemical Entity given the changes to metabolism and distribution of its major metabolite 5-FUInterim analysis of the NGC-Cap Phase 1b data shows improved safety, even with 5-FU

PCSA

News

LogicBio Therapeutics On Sept. 15, Co. Received Formal Notice From Nasdaq Staff Indicating That Staff Had Determined To Delist Co.’s Securities, Co. Says Intends To Timely Request A Hearing Before Nasdaq Hearings Panel

By Michael Horton

September 20, 5:22 PM

-Reuters

LOGC

Needham Downgrades NeoGenomics to Hold

Related Posts

The Latest Analyst Ratings for American Tower

B of A Securities Maintains Buy on Amazon.com, Lowers Price Target to $137

Processa Pharmaceuticals Provides Interim Analysis From Ongoing Phase 1b Trial Of Next Generation Capecitabine Showing Improved Safety Over Capecitabine

LogicBio Therapeutics On Sept. 15, Co. Received Formal Notice From Nasdaq Staff Indicating That Staff Had Determined To Delist Co.’s Securities, Co. Says Intends To Timely Request A Hearing Before Nasdaq Hearings Panel